Cargando…

Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions

Detalles Bibliográficos
Autor principal:	Alaibac, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915962/ https://www.ncbi.nlm.nih.gov/pubmed/29720979 http://dx.doi.org/10.3389/fimmu.2018.00810

Ejemplares similares

Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases
por: Olbrich, Michael, et al.
Publicado: (2019)

Skin Barrier and Autoimmunity—Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin
por: Stevens, Natalie E., et al.
Publicado: (2019)

Molecular Diagnosis in Autoimmune Skin Blistering Conditions
por: Otten, J.V., et al.
Publicado: (2014)

Editorial: Autoimmune Blistering Diseases
por: Kowalewski, Cezary, et al.
Publicado: (2020)

Patient genetics shape the autoimmune response in the blistering skin disease pemphigus vulgaris
por: Baker, John, et al.
Publicado: (2023)

Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases
por: Bosch-Amate, Xavier, et al.
Publicado: (2021)

Editorial: Autoimmune blistering diseases, volume II
por: Li, Xiaoguang, et al.
Publicado: (2023)

Role of Src and Cortactin in Pemphigus Skin Blistering
por: Kugelmann, Daniela, et al.
Publicado: (2019)

A life for autoimmune blistering diseases: in memoriam Detlef Zillikens
por: Hundt, Jennifer E., et al.
Publicado: (2023)

Occurrence of autoantibodies against skin proteins in patients with hereditary epidermolysis bullosa predisposes to development of autoimmune blistering disease
por: Lehr, Saskia, et al.
Publicado: (2022)

Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice
por: Mihai, Sidonia, et al.
Publicado: (2018)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Blistered Skin
Publicado: (1867)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody
por: Hou, Ying, et al.
Publicado: (2022)

Case Report: Concurrence of Dermatomyositis and Autoimmune Blistering Diseases: Two Case Reports and a Literature Review
por: Wu, Haixi, et al.
Publicado: (2022)

Diagnosis of Autoimmune Blistering Diseases
por: Witte, Mareike, et al.
Publicado: (2018)

Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases
por: Tseng, Henry, et al.
Publicado: (2023)

Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study
por: Sernicola, Alvise, et al.
Publicado: (2019)

Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
por: Du, Ying, et al.
Publicado: (2022)

Genome-wide mapping of gene–microbiota interactions in susceptibility to autoimmune skin blistering
por: Srinivas, Girish, et al.
Publicado: (2013)

The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid
por: Kamaguchi, Mayumi, et al.
Publicado: (2019)

Dermatomyositis in patients with autoimmune blistering diseases()()
por: Patsatsi, Aikaterini, et al.
Publicado: (2019)

IgM Deficiency in Autoimmune Blistering Mucocutaneous Diseases Following Various Treatments: Long Term Follow-Up and Relevant Observations
por: Ahmed, A. Razzaque, et al.
Publicado: (2021)

Correction: Simplified regimen of combined low-dose rituximab for autoimmune encephalitis with neuronal surface antibodies
por: Du, Ying, et al.
Publicado: (2022)

Dry skin and blistering in childhood
por: Dubois, A., et al.
Publicado: (2016)

Editorial: Skin Blistering Diseases
por: Has, Cristina, et al.
Publicado: (2019)

Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus
por: Lotti, Roberta, et al.
Publicado: (2018)

Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases
por: Bieber, Katja, et al.
Publicado: (2017)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
por: Ciolfi, Christian, et al.
Publicado: (2022)

The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases
por: Sitaru, Cassian, et al.
Publicado: (2007)

Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: An Australian case series
por: Cowan, Timothy L., et al.
Publicado: (2023)

Autoimmune blistering diseases in females: a review()()
por: Zhao, Cathy Y., et al.
Publicado: (2015)

Impact of COVID-19 on autoimmune blistering diseases
por: Drenovska, Kossara, et al.
Publicado: (2021)

Coagulation and Skin Autoimmunity
por: Cugno, Massimo, et al.
Publicado: (2019)

Editorial: Skin Autoimmunity
por: Kridin, Khalaf, et al.
Publicado: (2021)

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen
por: Hébert, Vivien, et al.
Publicado: (2021)

Ribosomal Protein S6-Ps240 Is Expressed in Lesional Skin from Patients with Autoimmune Skin Blistering Diseases
por: Abreu-Velez, Ana Maria, et al.
Publicado: (2013)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Mouse Models for Blistering Skin Disorders
por: Ganeshan, Radhika, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4ht6vssthluib2pkeke94tbodu